Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women☆,☆☆

https://doi.org/10.1016/0002-9378(86)90161-4Get rights and content

Abstract

Intravenous testosterone was infused for 6 hours in 23 ovulatory women, divided into five groups according to dose, to assess the effects of testosterone on gonadotropin secretion. Serum testosterone increased from 0.24 ± 0.08 to steady-state levels of 1.63 ± 0.18 ng/ml in the lowest-dose group (1) and to 42.1 ± 3.3 ng/ml in the highest-dose group (4). In another group (5), patients were pretreated with testolactone, which prevented the estradiol rise associated with testosterone infusion. All groups except group 1 exhibited significant reductions in the delta maximum responses of luteinizing hormone to gonadotropin-releasing hormone during testosterone infusion compared with pretreatment levels (p < 0.01). This was also evident for the testolactone group (5). There were no observed changes in serum follicle-stimulating hormone. Luteinizing hormone pulse frequency was decreased (p < 0.05) with testosterone concentrations of 27.2 ± 0.77 and 42.1 ± 3.3 ng/ml (groups 3 and 4), but only in the highest group (4) was there a decrease in pulse amplitude (p < 0.05). No luteinizing hormone pulse changes were observed with lower concentrations of testosterone. Plasma immunoreactive gonadotropin-releasing hormone levels remained undetectable or low in some of the groups sampled. These data suggest that short-term infusions of testosterone inhibit hypothalamic-pituitary function of normal women when high doses are used, and this effect may be independent of aromatization to estrogen.

References (18)

  • DR Mishell et al.

    Serum gonadotropins and steroid patterns during the normal menstrual cycle

    Am J Obstet Gynecol

    (1971)
  • J-P Louvet et al.

    Evidence for a role of androgens in follicular maturation

    Endocrinology

    (1975)
  • W Futterweit et al.

    Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals

    J Clin Endocrinol Metab

    (1986)
  • RJ Sherins et al.

    Studies on the role of sex steroids in the feedback control of FSH concentrations in men

    J Clin Endocrinol Metab

    (1973)
  • M Stewart-Bentley et al.

    The feedback control of luteinizing hormone in normal adult men

    J Clin Endocrinol Metab

    (1974)
  • RJ Santen

    Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men

    J Clin Invest

    (1975)
  • SSC Yen et al.

    Modulation of pituitary responsiveness to LRF by estrogen

    J Clin Endocrinol Metab

    (1974)
  • CF Wang et al.

    The role of estrogen in the modulation of pituitary sensitivity to LRF (luteinizing hormone-releasing factor) in men

    J Clin Endocrinol Metab

    (1975)
  • C Longcope et al.

    Conversion of blood androgens to estrogens in normal adult men and women

    J Clin Invest

    (1969)
There are more references available in the full text version of this article.

Cited by (59)

  • The impact of genetic steroid disorders on human fertility

    2023, Genetic Steroid Disorders: Second Edition

  • Pathological pulses in PCOS

    2019, Molecular and Cellular Endocrinology
    Citation Excerpt :

    Given that androgens antagonize progesterone negative feedback (Blank et al., 2009; Pielecka et al., 2006) the presence of hyperandrogenism at this pubertal stage would result in high frequency LH pulses in both the day and night, promoting even greater androgen production and further promotion of impaired negative feedback (Kim et al., 2018). Acute androgen administration to normal ovulatory women does not increase LH, in fact, it suppresses serum LH (Serafini et al., 1986). However, long term administration of androgen receptor antagonists to PCOS patients can ameliorate impaired negative feedback, indicating that chronic hyperandrogenism contributes to the impaired steroid hormone sensitivity of the GnRH neuronal network (Eagleson et al., 2000).

  • Polycystic Ovary Syndrome and Hyperandrogenic States

    2019, Yen &amp; Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth Edition

  • The impact of genetic steroid disorders on human fertility

    2017, Journal of Steroid Biochemistry and Molecular Biology
    Citation Excerpt :

    Treatment with androgen-blocking agents evokes a similar restoration of LH pulse frequency in hyper-androgenic individuals [10]. While such data is compelling, experiments involving infusion of androgens to healthy subjects as well as those with PCOS fails to alter basal LH secretion, and indeed can have the opposite effect, reducing serum LH levels [11,12]. Indeed, the role exerted by androgens on central gonadotropin pulsatility is complex and deserving of further study.

  • Fertility in patients with congenital adrenal hyperplasia

    2014, Fertility and Sterility
    Citation Excerpt :

    Such studies suggest that androgens may impede normal central feedback mechanisms. Not all evidence, however, supports this mechanism; infusion of androgens to women with PCOS as well as to normal controls did not alter basal LH secretion, and in fact high-dose exogenous androgens administered to normal women acutely reduced serum LH levels (23, 24). The exact effects of elevated androgens at the level of the hypothalamus and pituitary thus need to be further elucidated.

  • The Impact of Genetic Steroid Disorders on Human Fertility

    2014, Genetic Steroid Disorders
View all citing articles on Scopus
☆

This work was supported in part by National Institutes of Health Grant HD 17519 and National Institutes of Health, General Clinical Research Center Grant RR-43.

☆☆

Presented in part at the Thirty-second Annual Meeting of the Society for Gynecologic Investigation, Phoenix, Arizona, March 20–23, 1985.

View full text
Copyright © 1986 Published by Mosby, Inc.